Health Biogen and Sage Therapeutics Announce FDA Accepts Filing of New Drug Application and Grants Priority… Jason Junior Feb 6, 2023 <!-- Name:DistributionId Value:8743123 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4573 -->…
Health Zuranolone Eases Core Symptoms of Postpartum Depression Jason Junior Jul 1, 2021 Zuranolone proved safe and effective in reducing symptoms of postpartum depression in a phase III clinical trial. Patients who took zuranolone,…
Health Zuranolone Wins for Quick Depression Fix; Laughing Gas for Tx-Resistant Depression? Jason Junior Jun 24, 2021 The phase III WATERFALL study found that 50 mg of zuranolone (SAGE-217/BIIB125) -- a once-daily investigational oral agent given for 2 weeks…